槲皮素通过调节牛瘤胃上皮细胞中TLR4-NF-κB信号通路,缓解脂多糖诱导的细胞氧化应激和炎症反应。
Quercetin Alleviates Lipopolysaccharide-Induced Cell Oxidative Stress and Inflammatory Responses via Regulation of the TLR4-NF-κB Signaling Pathway in Bovine Rumen Epithelial Cells.
发表日期:2023 Aug 21
作者:
Maocheng Jiang, Kexin Wang, Yinghao Huang, Xuelei Zhang, Tianyu Yang, Kang Zhan, Guoqi Zhao
来源:
ANTIOXIDANTS & REDOX SIGNALING
摘要:
亚急性反刍酸中毒(SARA)将导致内毒素增加,对牛反刍胃上皮细胞(BREC)产生负面影响。黄酮类物质对内毒素引起的炎症具有很好的治疗效果。槲皮素是一种在水果和蔬菜中广泛存在的重要黄酮类物质,作为一种潜在的抗炎抗氧化剂引起了广泛关注。然而,槲皮素在抵抗脂多糖(LPS)引起的BREC损伤过程中的保护机制尚不清楚。本研究采用槲皮素和LPS诱导的BREC炎症模型,探讨槲皮素对LPS引起的BREC损伤的保护作用。将BREC分别用不同剂量的LPS(1、5和10 μg/mL)处理6小时或24小时,检测炎症因子的mRNA表达。实验结果表明,在1 μg/mL LPS处理6小时后,BREC中的前炎症细胞因子的mRNA高表达建立了BREC炎症模型。通过细胞计数试剂盒-8(CCK8)实验观察到80 μg/mL槲皮素对BREC生长的促进作用。槲皮素补充显著降低了炎症因子和趋化因子(尤其是肿瘤坏死因子α(TNF-α)、白细胞介素1β(IL-1β)、IL-6、CC趋化因子配体2(CCL2)、CCL20、CCL28和CXC趋化因子9(CXCL9))的表达水平。我们还通过qRT-PCR分析了相关通路的mRNA表达情况。验证实验结果表明槲皮素显著抑制了LPS处理的BREC中类胶质细胞柱状体联蛋白4(TLR4)和髓样分化原反应蛋白(MyD88)以及核因子κ-B(NF-κB)的mRNA表达。此外,西方印迹结果证实,LPS显著激活了p44/42外源性调节蛋白激酶(ERK1/2)和NF-κB的磷酸化,而添加槲皮素后此效应被逆转。为了辅助西方印迹结果,我们还通过免疫荧光法评估了p-ERK1/2和p-p65蛋白的表达情况,结果一致。因此,槲皮素抑制TLR4介导的NF-κB和MAPK信号通路的能力可能是其对LPS引起的BREC炎症反应产生抗炎作用的原因。根据这些结果,槲皮素可作为一种抗炎药物用于缓解高粒饲料引起的炎症,并为后期槲皮素的研发和利用奠定了概念基础。
Subacute rumen acidosis (SARA) will cause an increase in endotoxin, which will have a negative effect on the bovine rumen epithelial cells (BREC). Flavonoids are effective in treating inflammation caused by endotoxin. Quercetin is a vital flavonoid widely occurring in fruits and vegetables and has received significant interest as a prospective anti-inflammatory antioxidant. Nonetheless, quercetin's protective machinery against such damage to BREC induced by lipopolysaccharide (LPS) remains unclear. A combined quercetin and LPS-induced BREC inflammation model was utilized to elucidate the effect of quercetin protecting BREC from LPS-induced injury. After treating BREC with different doses of LPS (1, 5, and 10 μg/mL) for 6 h or 24 h, the mRNA expression of inflammatory factors was detected. Our experimental results show the establishment of the BREC inflammation model via mRNA high expression of pro-inflammatory cytokines in BREC following 6 h treatment with 1 µg/mL LPS. The promotive effect of 80 μg/mL quercetin on BREC growth via the cell counting kit-8 (CCK8) assay was observed. The expression of pro-inflammatory cytokines and chemokines, notably tumor necrosis factor α (TNF-α), Interleukin 1β (IL-1β), IL-6, CC-motif chemokine ligand 2 (CCL2), CCL20, CCL28, and CXC motif chemokine 9 (CXCL9), etc., was significantly reduced by quercetin supplementation. We also analyzed the mRNA detection of related pathways by qRT-PCR. Our validation studies demonstrated that quercetin markedly curbed the mRNA expression of the toll-like receptor 4 (TLR4) and myeloid differentiation primary response protein (MyD88) and the nuclear factor-κB (NF-κB) in LPS-treated BREC. In addition, western blot result outcomes confirmed, as expected, that LPS significantly activated phosphorylation of p44/42 extracellular regulated protein kinases (ERK1/2) and NF-κB. Unexpectedly, this effect was reversed by adding quercetin. To complement western blot results, we assessed p-ERK1/2 and p-p65 protein expression using immunofluorescence, which gave consistent results. Therefore, quercetin's capacity to bar the TLR4-mediated NF-κB and MAPK signaling pathways may be the cause of its anti-inflammatory effects on LPS-induced inflammatory reactions in BREC. According to these results, quercetin may be utilized as an anti-inflammatory medication to alleviate inflammation brought on by high-grain feed, and it also lays out a conceptual foundation regarding the development and utilization of quercetin in the later stage.